Transcenta Holding Pharmaceuticals-B (06628) has issued an announcement that on September 30, 2026, in replacement of previously granted awards that were cancelled, the company granted 30,000 new award shares (New Award Shares) to Professor Cheng Genhong (Professor Cheng) under the share incentive plan (the Grant).
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.